Received: 9 March 2022
Accepted: 29 April 2022
First Online: 6 May 2022
: Participation in the treatment was voluntary. The University of Utah’s Institutional Review Board deemed this case series to be service evaluation on 10/21/2021 and did not require ethical approval. Patients were informed their clinical data would be de-identified and used confidentially for clinical evaluation purposes.
: Publication consent was received from all participants.
: RR is employed by Novamind and has stock ownership in Novamind.